Found 4 hits of ic50 for monomerid = 50007416 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007416
(CHEMBL3237904)Show SMILES C[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1ccc(F)cc1)c1ccc(cc1)C(=O)NCCC(O)=O |r,wU:10.14,1.0,wD:7.8,c:5,(42.32,-42.86,;43.64,-42.07,;43.59,-40.54,;44.8,-39.59,;46.27,-40,;44.26,-38.14,;42.72,-38.2,;42.3,-39.68,;41.12,-38.69,;39.67,-39.22,;39.41,-40.74,;40.6,-41.73,;42.04,-41.19,;37.97,-41.27,;36.78,-40.29,;36.52,-41.81,;37.71,-42.79,;45.04,-36.81,;46.58,-36.82,;47.36,-35.49,;46.6,-34.15,;47.37,-32.82,;45.05,-34.14,;44.28,-35.47,;44.96,-42.86,;44.94,-44.4,;46.27,-45.19,;47.61,-44.44,;47.63,-42.9,;46.31,-42.11,;48.94,-45.23,;48.92,-46.76,;50.28,-44.47,;51.6,-45.26,;52.94,-44.5,;54.27,-45.29,;55.61,-44.53,;54.25,-46.82,)| Show InChI InChI=1S/C30H36FN3O4/c1-19(20-5-7-22(8-6-20)27(37)32-18-15-25(35)36)34-28(38)26(21-9-11-24(31)12-10-21)33-30(34)16-13-23(14-17-30)29(2,3)4/h5-12,19,23H,13-18H2,1-4H3,(H,32,37)(H,35,36)/t19-,23-,30-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 85 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from recombinant human GCGR expressed in CHO cells after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007416
(CHEMBL3237904)Show SMILES C[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1ccc(F)cc1)c1ccc(cc1)C(=O)NCCC(O)=O |r,wU:10.14,1.0,wD:7.8,c:5,(42.32,-42.86,;43.64,-42.07,;43.59,-40.54,;44.8,-39.59,;46.27,-40,;44.26,-38.14,;42.72,-38.2,;42.3,-39.68,;41.12,-38.69,;39.67,-39.22,;39.41,-40.74,;40.6,-41.73,;42.04,-41.19,;37.97,-41.27,;36.78,-40.29,;36.52,-41.81,;37.71,-42.79,;45.04,-36.81,;46.58,-36.82,;47.36,-35.49,;46.6,-34.15,;47.37,-32.82,;45.05,-34.14,;44.28,-35.47,;44.96,-42.86,;44.94,-44.4,;46.27,-45.19,;47.61,-44.44,;47.63,-42.9,;46.31,-42.11,;48.94,-45.23,;48.92,-46.76,;50.28,-44.47,;51.6,-45.26,;52.94,-44.5,;54.27,-45.29,;55.61,-44.53,;54.25,-46.82,)| Show InChI InChI=1S/C30H36FN3O4/c1-19(20-5-7-22(8-6-20)27(37)32-18-15-25(35)36)34-28(38)26(21-9-11-24(31)12-10-21)33-30(34)16-13-23(14-17-30)29(2,3)4/h5-12,19,23H,13-18H2,1-4H3,(H,32,37)(H,35,36)/t19-,23-,30-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 430 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Antagonist activity at human GCGR expressed in CHO cells assessed as inhibition of glucagon-stimulated cAMP production preincubated for 30 mins follo... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Mus musculus) | BDBM50007416
(CHEMBL3237904)Show SMILES C[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1ccc(F)cc1)c1ccc(cc1)C(=O)NCCC(O)=O |r,wU:10.14,1.0,wD:7.8,c:5,(42.32,-42.86,;43.64,-42.07,;43.59,-40.54,;44.8,-39.59,;46.27,-40,;44.26,-38.14,;42.72,-38.2,;42.3,-39.68,;41.12,-38.69,;39.67,-39.22,;39.41,-40.74,;40.6,-41.73,;42.04,-41.19,;37.97,-41.27,;36.78,-40.29,;36.52,-41.81,;37.71,-42.79,;45.04,-36.81,;46.58,-36.82,;47.36,-35.49,;46.6,-34.15,;47.37,-32.82,;45.05,-34.14,;44.28,-35.47,;44.96,-42.86,;44.94,-44.4,;46.27,-45.19,;47.61,-44.44,;47.63,-42.9,;46.31,-42.11,;48.94,-45.23,;48.92,-46.76,;50.28,-44.47,;51.6,-45.26,;52.94,-44.5,;54.27,-45.29,;55.61,-44.53,;54.25,-46.82,)| Show InChI InChI=1S/C30H36FN3O4/c1-19(20-5-7-22(8-6-20)27(37)32-18-15-25(35)36)34-28(38)26(21-9-11-24(31)12-10-21)33-30(34)16-13-23(14-17-30)29(2,3)4/h5-12,19,23H,13-18H2,1-4H3,(H,32,37)(H,35,36)/t19-,23-,30-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from GCGR in mouse liver membranes after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50007416
(CHEMBL3237904)Show SMILES C[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1ccc(F)cc1)c1ccc(cc1)C(=O)NCCC(O)=O |r,wU:10.14,1.0,wD:7.8,c:5,(42.32,-42.86,;43.64,-42.07,;43.59,-40.54,;44.8,-39.59,;46.27,-40,;44.26,-38.14,;42.72,-38.2,;42.3,-39.68,;41.12,-38.69,;39.67,-39.22,;39.41,-40.74,;40.6,-41.73,;42.04,-41.19,;37.97,-41.27,;36.78,-40.29,;36.52,-41.81,;37.71,-42.79,;45.04,-36.81,;46.58,-36.82,;47.36,-35.49,;46.6,-34.15,;47.37,-32.82,;45.05,-34.14,;44.28,-35.47,;44.96,-42.86,;44.94,-44.4,;46.27,-45.19,;47.61,-44.44,;47.63,-42.9,;46.31,-42.11,;48.94,-45.23,;48.92,-46.76,;50.28,-44.47,;51.6,-45.26,;52.94,-44.5,;54.27,-45.29,;55.61,-44.53,;54.25,-46.82,)| Show InChI InChI=1S/C30H36FN3O4/c1-19(20-5-7-22(8-6-20)27(37)32-18-15-25(35)36)34-28(38)26(21-9-11-24(31)12-10-21)33-30(34)16-13-23(14-17-30)29(2,3)4/h5-12,19,23H,13-18H2,1-4H3,(H,32,37)(H,35,36)/t19-,23-,30-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 7.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Antagonist activity at human GLP-1R expressed in CHO cells assessed as inhibition of GLP-1-stimulated cAMP production preincubated for 30 mins follow... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Search and Browse
